Target intelligence / Profile preview

STARD4 antisense RNA 1 (STARD4-AS1)

Target
STARD4-AS1
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA
01

Overview

STARD4 antisense RNA 1 (STARD4-AS1) is a long non-coding RNA transcribed from the antisense strand of the STARD4 gene locus on chromosome 5. It does not encode a protein but regulates cellular processes through RNA-mediated mechanisms. STARD4-AS1 has been implicated in the regulation of ferroptosis and necroptosis, two forms of programmed cell death relevant to cancer biology. It is differentially expressed in oral squamous cell carcinoma, where lower expression is associated with tumor cells, and functional studies suggest that knockdown of STARD4-AS1 can inhibit cancer cell proliferation and migration, while promoting ferroptosis. It is considered a biomarker for prognosis in certain cancers and is a candidate for RNA-based therapeutics targeting cancer and immune modulation.

Other names
CTC-426B10.1STARD4-AS1steroidogenic acute regulator protein-related lipid transfer domain containing 4-antisense RNA 1STARD4 antisense RNA 1 (non-protein coding)GC05P110849GC05P111514GC05P111539GC05P111552GC05P111567GC05P111581GC05P111592
02

Mechanism of action

Regulation of ferroptosis and necroptosis pathways via lncRNA-mediated gene expression control. Potentially modulates chemosensitivity and cellular response to antitumor agents.

03

Biological functions

Regulation of ferroptosisRegulation of necroptosisModulation of cell proliferationModulation of cell deathImmune regulation
04

Disease associations

Cancer (notably oral squamous cell carcinoma)Acute myeloid leukemiaGlioma susceptibilityAlström syndrome (associative)
05

Safety considerations

No specific drug safety concerns are established for STARD4-AS1 modulation; the implications are under investigation as siRNA/ASO targets for cancer
06

Interacting drugs

Cisplatin

3 more in the full profile.

07

Biomarkers

Prognostic biomarker for oral squamous cell carcinoma and acute myeloid leukemiaBiomarker for immune response modulation (in cancer and leukemia)

Beyond the preview

Go deeper on STARD4 antisense RNA 1 (STARD4-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STARD4 antisense RNA 1 (STARD4-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call